The funding rounds that used to precede an IPO are less common than in 2020 and 2021, leaving venture firms to pick up the slack.Cancer drug startup CG Oncology ticks many of the criteria biotechnology companies need to pull off an initial public offering in today’s market.Its lead drug candidate is in a Phase 3 […]